Bengaluru (Karnataka) [India], April 21 (ANI/PRNewswire): Flutura Business Solutions LLC, an Industrial IoT Intelligence provider, is collaborating with global pharma major Lupin Limited (Lupin) to accelerate its digital transformation and automation journey.
New Delhi [India], August 21 (ANI): There will be more clarity on the price of its COVID-19 vaccine ZyCOV-D by next week, said Managing Director of Zydus Group Dr Sharvil Patel on Saturday.
Mumbai (Maharashtra) [India], August 11 (ANI): Pharma major Lupin Ltd has reported consolidated sales of Rs 4,237 crore in the first quarter of current financial year (Q1 FY22), up 13 per cent from Rs 3,759 crore in the previous quarter (Q4 FY21).
Hyderabad (Telangana) [India], July 30 (ANI): Vice President M Venkaiah Naidu on Friday visited pharma major Bharat Biotech's COVID-19 vaccine manufacturing facility in Hyderabad.
New Delhi [India], July 23 (ANI): An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
New Delhi [India], June 29 (ANI): The Mumbai-based pharmaceutical multinational Cipla, on behalf of the US pharma major Moderna, has requested for import and marketing authorisation of its COVID-19 vaccines.
Mumbai (Maharashtra) [India], May 13 (ANI): Pharma major Lupin Ltd on Thursday reported 18 per cent jump in its consolidated profit after tax to Rs 460 crore.
Bengaluru (Karnataka) [India], March 2 (ANI/PRNewswire): Global pharma major Lupin Limited (Lupin) and Silicon Valley-based enterprise automation start-up JIFFY.ai have announced a formalized partnership where JIFFY.ai will help to strategically expand Lupin's automation initiatives.
Bengaluru (Karnataka) [India], January 8 (ANI): Former HDFC Bank's Managing Director Aditya Puri has joined pharma major Strides Group as an advisor and will also serve as a director of its associate company Stelis Biopharma.
Ahmedabad (Gujarat) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday arrived in Ahmedabad and proceeded to Zydus Biotech Park of the pharma major Zydus Cadila to review the vaccine development.
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
Mumbai (Maharashtra) [India], September 15 (ANI): Equity benchmark indices traded higher with narrow gains during early hours on Tuesday amid positive sentiment across global markets.